Literature DB >> 3693758

Basidiomycete allergy: measurement of spore-specific IgE antibodies.

B T Butcher1, C E O'Neil, M A Reed, L C Altman, M Lopez, S B Lehrer.   

Abstract

RAST with 12 basidiospore extracts demonstrated that a significant percent of 42 individuals with symptoms of perennial rhinitis and/or asthma and skin reactivity to at least one spore extract had spore-specific IgE antibodies. These antibodies were not demonstrable in 14 atopic, symptomatic, skin test negative control subjects nor in five nonatopic, asymptomatic control subjects. There was a statistically significant association between RAST and skin test results for all but three of the spore extracts. A statistically significant association was also observed between RAST results obtained with most of the different spore extracts. A similar association was present for skin test results with different spore extracts. These results provide evidence that basidiospore extracts are suitable allergens for use in diagnostic studies of respiratory disease associated with exposure to basidiomycetes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3693758     DOI: 10.1016/s0091-6749(87)80269-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

Review 1.  Basidiospore aeroallergens.

Authors:  W E Horner; C E O'Neil; S B Lehrer
Journal:  Clin Rev Allergy       Date:  1992

Review 2.  Mushroom poisoning by Chlorophyllum molybdites in the Midwest United States. Cases and a review of the syndrome.

Authors:  P F Lehmann; U Khazan
Journal:  Mycopathologia       Date:  1992-04       Impact factor: 2.574

Review 3.  Fungal allergens.

Authors:  W E Horner; A Helbling; J E Salvaggio; S B Lehrer
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

4.  The effects of meteorological factors on the occurrence of Ganoderma sp. spores in the air.

Authors:  Agnieszka Grinn-Gofroń; Agnieszka Strzelczak
Journal:  Int J Biometeorol       Date:  2010-05-29       Impact factor: 3.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.